newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit

Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, announced today that members of the management team will participate